Aurobindo receives FDA nod for posaconazole delayed-release tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application posaconazole delayed-release tablets 100mg.